21 research outputs found

    Wrist-Worn RFID Antenna Printed on Additive Manufactured Flexible Substrate

    Get PDF
    We assess the feasibility of fabricating a flexible RFID wrist-worn antenna printed on a substrate manufactured using 3D-printing technology, as to enable full customization of the bracelet at low cost. Numerical results show adequate power transmission to the RFID chip. Also, the fabricated prototype shows enough flexibility to be bent around the wrist.info:eu-repo/semantics/acceptedVersio

    Hyperglycemia and nocturnal systolic blood pressure are associatedwith left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients

    Get PDF
    BACKGROUND: The aim of this study was to determine if hypertensive type 2 diabetic patients, when compared to patients with essential hypertension have an increased left ventricular mass index (LVMI) and a worse diastolic function, and if this fact would be related to 24-h pressoric levels changes. METHODS: Ninety-one hypertensive patients with type 2 diabetes mellitus (DM) (group-1 [G1]), 59 essential hypertensive patients (group-2 [G2]) and 26 healthy controls (group-3 [G3]) were submitted to 24-h Ambulatory Blood Pressure Monitoring (ABPM) and echocardiography (ECHO) with Doppler. We calculated an average of fasting blood glucose (AFBG) values of G1 from the previous 4.2 years and a glycemic control index (GCI) (percentual of FBG above 200 mg/dl). RESULTS: G1 and G2 did not differ on average of diurnal systolic and diastolic BP. However, G1 presented worse diastolic function and a higher average of nocturnal systolic BP (NSBP) and LVMI (NSBP = 132 ± 18 vs 124 ± 14 mmHg; P < 0.05 and LVMI = 103 ± 27 vs 89 ± 17 g/m(2); P < 0.05, respectively). In G1, LVMI correlated with NSBP (r = 0.37; P < 0.001) and GCI (r = 0.29; P < 0.05) while NSBP correlated with GCI (r = 0.27; P < 0.05) and AFBG (r = 0.30; P < 0.01). When G1 was divided in tertiles according to NSBP, the subgroup with NSBP≥140 mmHg showed a higher risk of LVH. Diabetics with NSBP≥140 mmHg and AFBG>165 mg/dl showed an additional risk of LVH (P < 0.05; odds ratio = 11). In multivariate regression, both GCI and NSBP were independent predictors of LVMI in G1. CONCLUSION: This study suggests that hyperglycemia and higher NSBP levels should be responsible for an increased prevalence of LVH in hypertensive patients with Type 2 DM

    Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Hypertensive patients with reduced blood pressure fall (BPF) at night are at higher risk of cardiovascular events (CVE).</p> <p>Methods</p> <p>We evaluated in hypertensive diabetic patients, if a reduced nocturnal BPF can precedes the development of diabetic nephropathy (DN). We followed 70 patients with normal urinary albumin excretion (UAE) for two years. We performed 24-hours ambulatory BP monitoring in baseline and at the end of the study.</p> <p>Results</p> <p>Fourteen (20%) patients (GI) developed DN (N = 11) and/or CVE (n = 4). Compared to the remaining 56 patients (GII) in baseline, GI had similar diurnal systolic (SBP) and diastolic BP (DBP), but higher nocturnal SBP (138 ± 15 vs 129 ± 16 mmHg; p < 0.05) and DBP (83 ± 12 vs 75 ± 11 mmHg; p < 0,05). Basal nocturnal SBP correlated with occurrence of DN and CVE (R = 0.26; P < 0.05) and with UAE at the end of the study (r = 0.3; p < 0.05). Basal BPF (%) correlated with final UAE (r = -0.31; p < 0.05). In patients who developed DN, reductions occurred in nocturnal systolic BPF (12 ± 5 vs 3 ± 6%, p < 0,01) and diastolic BPF (15 ± 8 vs 4 ± 10%, p < 0,01) while no changes were observed in diurnal SBP (153 ± 17 vs 156 ± 16 mmHg, NS) and DBP (91 ± 9 vs 90 ± 7 mmHg, NS). Patients with final UAE < 20 μg/min, had no changes in nocturnal and diurnal BP.</p> <p>Conclusions</p> <p>Our results suggests that elevations in nocturnal BP precedes DN and increases the risk to develop CVE in hypertensive patients with T2DM.</p

    Gestão por competências em organizações de governo

    Get PDF
    Ao longo dos últimos anos vem se ampliando os espaços e o interesse, no meio acadêmico e empresarial, pelas discussões sobre uso da abordagem da competência como marco importante para as atividades de gestão de recursos humanos. A difusão dessa abordagem entre as organizações públicas brasileiras é, entretanto, bem mais recente, e conta, ainda hoje, com um número insuficiente de estudos e publicações. É esta a razão da importância e pertinência da publicação do livro " Gestão por competências em organizações de governo"Número de páginas: 100 p.Gestão de PessoasISBN 85-256-0046-

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

    Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population

    No full text
    Vitamin D has been considered a strong contributing factor to type 1 diabetes mellitus (T1DM). Many studies have investigated polymorphisms in the VDR gene in association with T1DM in different populations, but there are still conflicting findings. This study aimed to evaluate the association of four variants in the VDR gene (rs7975232, rs1544410, rs731236, and rs2228570) with T1DM risk and vitamin D levels within a population from North Region, Brazil, as well as the influence of genomic ancestry on T1DM. A total of 65 T1DM patients and 83 non-T1DM patients were enrolled in this study. VDR gene polymorphisms were assessed using Sanger sequencing analysis. Genomic ancestry was analyzed using a set of 61 ancestry-informative markers. T1DM patients showed higher European genomic contribution and lower Native American genomic contribution when compared to non-T1DM patients. T1DM patients with AA genotype in rs1544410 or CC genotype in rs731236 had significantly lower 25(OH)D levels compared to the other two genotypes (p = 0.013 and p = 0.02, respectively), while T1DM with TT genotype in rs2228570 had higher 25(OH)D levels compared to CC + TC in the same polymorphism (p = 0.011). Our findings suggest that the association between 25(OH)D and T1DM may be modified by VDR variants, possibly influencing the development of this autoimmune disease

    Isokinetic performance of knee flexor and extensor muscles in community-dwelling elderly women

    No full text
    Introduction: The isokinetic dynamometer enables accurate assessment of muscle function. In Brazil, few studies have assessed the isokinetic muscle performance in older adults making interpretation and comparison of results with other studies. Objectives: To conduct a descriptive analysis of the performance of the muscle flexor and extensor muscles of the knee joint in elderly community and compare the performance between the age groups 65-74 years and 75 years or more. Methods: This is a cross sectional observational study with a convenience sample of 229 elderly community. For the analysis of muscle performance was used isokinetic dynamometer (Biodex System 3 Pro) in the angular velocities of 60 °/s and 180 °/s. The variables evaluated were peak torque, peak torque normalized by body weight, total work normalized by body mass, total work, average power and agonist/antagonist ratio. Descriptive analysis was used to characterize the sample. For comparison between age groups was used Student´s t-test with e#945; = 0.05. Results: The elderly women with older age showed a statistically significant decrease in most of the variables (p elt; 0.05) except for the agonist and antagonist knee (p = 0.398). Conclusions: The isokinetic was a sensitive tool to characterize the modifications caused by aging on muscle function. Elderly with results below the lower limits of the confidence intervals for all variables certainly has a decreased strength for the age group evaluated and must be addressed therapeutically. The results can be used as a benchmark in clinical practice and future research

    Isokinetic performance of knee flexor and extensor muscles in community-dwelling elderly women

    No full text
    AbstractIntroduction The isokinetic dynamometer enables accurate assessment of muscle function. In Brazil, few studies have assessed the isokinetic muscle performance in older adults making interpretation and comparison of results with other studies.Objectives To conduct a descriptive analysis of the performance of the muscle flexor and extensor muscles of the knee joint in elderly community and compare the performance between the age groups 65-74 years and 75 years or more.Methods This is a cross sectional observational study with a convenience sample of 229 elderly community. For the analysis of muscle performance was used isokinetic dynamometer (Biodex System 3 Pro™) in the angular velocities of 60 °/s and 180 °/s. The variables evaluated were peak torque, peak torque normalized by body weight, total work normalized by body mass, total work, average power and agonist/antagonist ratio. Descriptive analysis was used to characterize the sample. For comparison between age groups was used Student's t-test with α = 0.05.Results The elderly women with older age showed a statistically significant decrease in most of the variables (p < 0.05) except for the agonist and antagonist knee (p = 0.398).Conclusions The isokinetic was a sensitive tool to characterize the modifications caused by aging on muscle function. Elderly with results below the lower limits of the confidence intervals for all variables certainly has a decreased strength for the age group evaluated and must be addressed therapeutically. The results can be used as a benchmark in clinical practice and future research
    corecore